PVR Interpretation: Two Distinct Clinical Contexts
I need to clarify that "PVR" has two completely different meanings in clinical medicine, and your interpretation depends entirely on the clinical context.
Context 1: Pulse Volume Recording (PVR) - Peripheral Arterial Disease
PVRs provide qualitative waveform analysis of limb perfusion to detect peripheral arterial disease and localize stenoses. 1
How PVR Works
- PVRs are created by inflating pneumoplethysmography cuffs at predetermined levels on each limb, measuring miniscule volume changes with each pulse to create waveform tracings. 1
- The technique relies on limb volume change rather than pressure, making it particularly valuable in patients with noncompressible vessels (common in diabetes and chronic renal insufficiency where ankle-brachial index fails). 1
Waveform Interpretation
- Compare waveforms at sequential levels to determine segmental disease and assess arterial blood flow quality at each station simultaneously. 1
- Normal waveforms show sharp upstrokes and prominent dicrotic notches. 1
- Abnormal waveforms demonstrate blunted upstrokes, absent dicrotic notches, and decreased amplitude, indicating hemodynamically significant stenosis proximal to that level. 1
Clinical Application
- Use PVR in conjunction with ankle-brachial index and segmental pressure measurements for comprehensive peripheral arterial disease assessment. 1
- PVR is especially useful when ankle-brachial index >1.3 indicates noncompressible vessels. 1
- The test provides insight into disease location but cannot determine precise severity or number of lesions. 1
Context 2: Pulmonary Vascular Resistance (PVR) - Pulmonary Hypertension
PVR >3 Wood units combined with mean pulmonary artery pressure >25 mmHg is required to diagnose pulmonary arterial hypertension after excluding left heart disease, lung disease, and thromboembolic disease. 1
PVR Calculation Formula
- PVR = (mean pulmonary artery pressure - pulmonary capillary wedge pressure) / cardiac output 2
- Units: Wood units (normal <2-3 Wood units) or dynes·s·cm⁻⁵ (multiply Wood units by 80 for conversion). 2
- All measurements must be obtained via right heart catheterization—echocardiographic estimates are unreliable for diagnosis. 1
Required Measurements
- Mean pulmonary artery pressure (mPAP) measured via right heart catheterization 2
- Pulmonary capillary wedge pressure (PCWP) obtained by wedging balloon catheter in pulmonary arterial branch, measured at end-expiration 1, 2
- Cardiac output via thermodilution (triplicate measurements) or Fick method (preferred if severe tricuspid regurgitation present) 1, 2
Diagnostic Interpretation
- PVR distinguishes passive pulmonary hypertension (elevated mPAP, normal PVR) from pulmonary vascular disease (elevated mPAP, elevated PVR). 1
- Normal PVR with elevated mPAP suggests left heart disease, valvular disease, or high-flow states (anemia, pregnancy, sepsis, thyrotoxicosis). 1
- Transpulmonary gradient (mPAP - PCWP) >20 mmHg with PVR >3 Wood units indicates disproportionate pulmonary vascular involvement even in left heart disease. 1
Critical Clinical Caveats
- In patients with tricuspid regurgitation and right ventricular dilatation, thermodilution cardiac output measurements can be erroneous, compromising PVR calculation accuracy. 1, 2
- During mechanical ventilation with high PEEP, calculate transmural PCWP to estimate true left ventricular filling pressure. 1, 2
- In ARDS, calculated PVR may underestimate true pulmonary vascular resistance due to extended West zones 1 and 2; transpulmonary pressure gradient remains valuable. 1
Units Confusion Warning
- Significant variability exists in PVRI (PVR index) reporting—only 45.4% of published literature uses correct units ending in m² (meters squared). 3
- Always verify whether reported values are PVR (Wood units) or PVRI (Wood units·m²) to avoid life-altering misinterpretation. 3
Emerging Evidence on Borderline PVR
- Patients with precapillary pulmonary hypertension and PVR 2-3 Wood units (below diagnostic threshold) still demonstrate adverse outcomes with 5-year survival of 84%. 4
- These borderline patients appear to respond to pulmonary arterial hypertension therapy, though this requires validation in randomized trials. 4
Determining Which PVR You Need
If the clinical question involves: